World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma.
about
Role of the microbiome in non-gastrointestinal cancersOxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesisDaclatasvir-based Treatment Regimens for Hepatitis C Virus Infection: A Systematic Review and Meta-AnalysisVirus-induced hepatocellular carcinoma with special emphasis on HBV.Global epidemiology and burden of HCV infection and HCV-related disease.Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.Diversity of the association of serum levels and genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis CUp-regulation of CDK16 by multiple mechanisms in hepatocellular carcinoma promotes tumor progression.Effects of interactions between environmental factors and KIF1B genetic variants on the risk of hepatocellular carcinoma in a Chinese cohortLong noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transitionBlood glucose concentration and risk of liver cancer: systematic review and meta-analysis of prospective studies.Global, cancer-specific microRNA cluster hypomethylation was functionally associated with the development of non-B non-C hepatocellular carcinoma.Genome-wide association study identified PLCE1- rs2797992 and EGFR- rs6950826 were associated with TP53 expression in the HBV-related hepatocellular carcinoma of Chinese patients in GuangxiAdeno-Associated Virus 2-Mediated Hepatocellular Carcinoma is Very Rare in Korean Patients.Reversal of multidrug resistance of hepatocellular carcinoma cells by metformin through inhibiting NF-κB gene transcriptionGenetic polymorphisms of immune checkpoint proteins PD-1 and TIM-3 are associated with survival of patients with hepatitis B virus-related hepatocellular carcinoma.MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C.Prognostic value of fever grade combined with neutrophil percentage in hepatocellular carcinoma patients presenting fever as the initial manifestation.Phase I study of nintedanib in Japanese patients with advanced hepatocellular carcinoma and liver impairment.Needle track seeding after radiofrequency ablation for hepatocellular carcinoma: prevalence, impact, and management challenge.Hepatitis C virus seroprevalence in the general female population of 9 countries in Europe, Asia and Africa.Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization's global health sector strategy core indicators and scaling up key interventions.Pyroptosis is involved in the pathogenesis of human hepatocellular carcinoma.Quantitative proteomics by SWATH-MS reveals sophisticated metabolic reprogramming in hepatocellular carcinoma tissues.Liver cirrhosis stages and the incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving antiviral therapy.Increasing Burden of Liver Cancer Despite Extensive Use of Antiviral Agents in a Hepatitis B Virus-Endemic Population.Rationally combining anti-VEGF therapy with checkpoint inhibitors in hepatocellular carcinoma.Cooperative effects of hepatitis B virus and TNF may play important roles in the activation of metabolic pathways through the activation of NF-κB.The paradoxical changes of membrane and soluble herpes virus entry mediator in hepatocellular carcinoma patients.Antigen-specific T cell response from dendritic cell vaccination using side population cell-associated antigens targets hepatocellular carcinoma.Higher Risk of Hepatocellular Carcinoma in Chronic Hepatitis B vs Chronic Hepatitis C after Achievement of Virologic Response.Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer.The impact of chronic hepatitis C infection on cholesterol metabolism in PBMCs is associated with microRNA-146a expression.Cancer incidence and cancer control in Mongolia: Results from the National Cancer Registry 2008-12.Interplay between viruses and bacterial microbiota in cancer development.Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?Risk of hepatitis B virus-related hepatocellular carcinoma development is much higher in Koreans than in Taiwanese.Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA.The higher prevalence of truncal obesity and diabetes in American than Chinese patients with chronic hepatitis C might contribute to more rapid progression to advanced liver disease.Clustering infection of hepatitis B virus genotype B4 among residents in Vietnam, and its genomic characters both intra- and extra-family.
P2860
Q26747710-F58E685A-70BC-45F0-BA44-D59EBC2FCA3FQ28075646-4DCDE04B-35EF-4D0D-9D83-85CE9ED58886Q28077287-CE83CD27-8F66-4478-931C-2ABE63252677Q30238961-5E8572A8-A75E-4765-981C-87138E75EBF5Q30240220-D1C86C6A-215F-4175-AD65-6D4C145EBEF6Q30746254-CB20DB27-C3AD-4467-A8A5-BAA79FC99923Q33779175-6927D55C-9D5A-40BA-957F-4130B5C819CCQ33913172-D0640AB3-DFB8-4CD4-8E04-8B9E19BA913FQ36001469-D5577517-F511-4A7B-869E-4557A7960613Q36144048-04129D42-36AE-4BF1-B9E1-EDF39E8EB61CQ36353953-06D4CFC3-3EEB-462D-9B8B-6CA56C03143FQ36855799-6EE3F607-880F-4702-B2DF-B7FBBC80C5A2Q36879598-48D716A9-6A2D-482D-AEF4-60D5CDB54B00Q37084152-00610D10-C4A3-4F09-A51A-4756F8566A29Q37188573-DAD07AC7-80B4-4F41-A28F-37FD9DCFD797Q37295612-89CD1BFA-6B40-4ABC-B8F6-B66EE5373654Q37330550-EB4B29F0-1166-48BC-8EFF-5583F6A10A5AQ37354173-8A20E65B-202F-4D69-A579-F705D5F22191Q37544401-F3AE3DA8-D7C6-470D-BB00-A8AC604B2005Q37608627-24E221D8-9254-4F95-8F16-B310F83D1E80Q37620782-11D0ABF3-BCDD-4BC8-8265-3010F7B9044AQ37708535-DCB7E776-0A6D-480C-9995-23957B7E437FQ37708998-2B0869EC-E519-4E2C-97AA-30B8DD83CC4DQ37738005-115C04EA-5913-4231-A7E7-68005F3A012BQ38676705-F1C4BE76-AAD3-4483-9CCF-34DE01AC602FQ38719026-0E6980F3-BA77-481F-B5F8-10DC6626E237Q38728953-BFDB3D32-A6B6-4687-B1EE-D237B599C0A0Q38763779-4FAF5C66-3375-493E-A0B1-68DD9096E163Q38781597-52A6D1C2-9851-426E-BB03-3251086ED7D7Q38788212-8EB875A9-DA97-4ADE-80B8-900A72B06FD8Q38789115-16EE6364-FFFE-44FC-A5B0-474A8169BF96Q39006737-A87331D1-9C16-4430-98F0-A2BE92F10DEBQ39152911-E2B6CE63-8D7D-4DF2-9E30-BD96A6F933D3Q39311762-1241740C-B7F1-4B79-B110-2C3BCCFC98F0Q39365350-DD958543-8C9A-4C4D-B87F-891D145140B6Q39546902-84DDC0F9-2C60-4477-9BB1-294A4B25D8A1Q40058888-17D433C8-6598-4008-A4C0-F94D43E41D9BQ40068189-38761621-5D24-442D-86E1-A3C4BFB49C3BQ40073825-C2B36A75-38E3-4900-8818-1BB61D9D8AA6Q40104105-5FA92723-E732-4620-9F06-58F81DC84469
P2860
World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 July 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
World-wide relative contributi ...... s in hepatocellular carcinoma.
@en
World-wide relative contributi ...... s in hepatocellular carcinoma.
@nl
type
label
World-wide relative contributi ...... s in hepatocellular carcinoma.
@en
World-wide relative contributi ...... s in hepatocellular carcinoma.
@nl
prefLabel
World-wide relative contributi ...... s in hepatocellular carcinoma.
@en
World-wide relative contributi ...... s in hepatocellular carcinoma.
@nl
P2860
P50
P921
P356
P1433
P1476
World-wide relative contributi ...... s in hepatocellular carcinoma.
@en
P2093
Catherine de Martel
P2860
P304
P356
10.1002/HEP.27969
P407
P5008
P577
2015-07-03T00:00:00Z
2015-10-01T00:00:00Z